BioLineRx (BLRX) Reports Q3 Loss of $0.06/Share
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.06), versus ($0.03) reported last year.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.06), versus ($0.03) reported last year.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.